Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice

Alistair J. Barber, Peter H. Yu, Alan A. Boulton

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In order to measure the chronic effects of monoamine oxidase-B (MAO-B) inhibitors on the physical and cognitive condition of 60 aged male mice, l-deprenyl or N-methyl-N-(2-pentyl)-propargylamine (M-2-PP) were administered in drinking water (10 μg/ml/day) for 37 weeks. The spontaneous open-field locomotion, balancing ability and weight gain of the mice were assessed continuously. At the end of the study the spatial learning ability of all surviving mice was assessed in a Morris water maze. Both drug groups exhibited a reduction in spontaneous locomotion at the same rate as the control group, while there were no changes in balancing ability. The mice receiving l-deprenyl, however, performed the water maze task less well than the control group. The mice receiving l-deprenyl also gained weight at a significantly reduced rate compared to both the M-2-PP and water treated groups. A brain MAO assay indicated that MAO-B was completely inhibited by both drugs while MAO-A remained unchanged. The implications of these data on longevity studies using l-deprenyl and other MAO-B inhibitors are discussed.

Original languageEnglish (US)
Pages (from-to)739-747
Number of pages9
JournalLife Sciences
Volume53
Issue number9
DOIs
StatePublished - 1993

Fingerprint

Monoamine Oxidase Inhibitors
Monoamine Oxidase
Selegiline
Aptitude
Locomotion
Water
Control Groups
Drinking Water
Pharmaceutical Preparations
Weight Gain
Assays
Brain
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Barber, Alistair J. ; Yu, Peter H. ; Boulton, Alan A. / Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice. In: Life Sciences. 1993 ; Vol. 53, No. 9. pp. 739-747.
@article{5bffa7d36cd6481cbe0e46382bdc156d,
title = "Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice",
abstract = "In order to measure the chronic effects of monoamine oxidase-B (MAO-B) inhibitors on the physical and cognitive condition of 60 aged male mice, l-deprenyl or N-methyl-N-(2-pentyl)-propargylamine (M-2-PP) were administered in drinking water (10 μg/ml/day) for 37 weeks. The spontaneous open-field locomotion, balancing ability and weight gain of the mice were assessed continuously. At the end of the study the spatial learning ability of all surviving mice was assessed in a Morris water maze. Both drug groups exhibited a reduction in spontaneous locomotion at the same rate as the control group, while there were no changes in balancing ability. The mice receiving l-deprenyl, however, performed the water maze task less well than the control group. The mice receiving l-deprenyl also gained weight at a significantly reduced rate compared to both the M-2-PP and water treated groups. A brain MAO assay indicated that MAO-B was completely inhibited by both drugs while MAO-A remained unchanged. The implications of these data on longevity studies using l-deprenyl and other MAO-B inhibitors are discussed.",
author = "Barber, {Alistair J.} and Yu, {Peter H.} and Boulton, {Alan A.}",
year = "1993",
doi = "10.1016/0024-3205(93)90251-W",
language = "English (US)",
volume = "53",
pages = "739--747",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "9",

}

Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice. / Barber, Alistair J.; Yu, Peter H.; Boulton, Alan A.

In: Life Sciences, Vol. 53, No. 9, 1993, p. 739-747.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice

AU - Barber, Alistair J.

AU - Yu, Peter H.

AU - Boulton, Alan A.

PY - 1993

Y1 - 1993

N2 - In order to measure the chronic effects of monoamine oxidase-B (MAO-B) inhibitors on the physical and cognitive condition of 60 aged male mice, l-deprenyl or N-methyl-N-(2-pentyl)-propargylamine (M-2-PP) were administered in drinking water (10 μg/ml/day) for 37 weeks. The spontaneous open-field locomotion, balancing ability and weight gain of the mice were assessed continuously. At the end of the study the spatial learning ability of all surviving mice was assessed in a Morris water maze. Both drug groups exhibited a reduction in spontaneous locomotion at the same rate as the control group, while there were no changes in balancing ability. The mice receiving l-deprenyl, however, performed the water maze task less well than the control group. The mice receiving l-deprenyl also gained weight at a significantly reduced rate compared to both the M-2-PP and water treated groups. A brain MAO assay indicated that MAO-B was completely inhibited by both drugs while MAO-A remained unchanged. The implications of these data on longevity studies using l-deprenyl and other MAO-B inhibitors are discussed.

AB - In order to measure the chronic effects of monoamine oxidase-B (MAO-B) inhibitors on the physical and cognitive condition of 60 aged male mice, l-deprenyl or N-methyl-N-(2-pentyl)-propargylamine (M-2-PP) were administered in drinking water (10 μg/ml/day) for 37 weeks. The spontaneous open-field locomotion, balancing ability and weight gain of the mice were assessed continuously. At the end of the study the spatial learning ability of all surviving mice was assessed in a Morris water maze. Both drug groups exhibited a reduction in spontaneous locomotion at the same rate as the control group, while there were no changes in balancing ability. The mice receiving l-deprenyl, however, performed the water maze task less well than the control group. The mice receiving l-deprenyl also gained weight at a significantly reduced rate compared to both the M-2-PP and water treated groups. A brain MAO assay indicated that MAO-B was completely inhibited by both drugs while MAO-A remained unchanged. The implications of these data on longevity studies using l-deprenyl and other MAO-B inhibitors are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0027183289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027183289&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(93)90251-W

DO - 10.1016/0024-3205(93)90251-W

M3 - Article

C2 - 8355573

AN - SCOPUS:0027183289

VL - 53

SP - 739

EP - 747

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 9

ER -